Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 3
2007 1
2009 2
2010 4
2011 9
2012 18
2013 23
2014 23
2015 7
2016 1
2018 3
2019 6
2020 4
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 22713135

93 results

Results by year

Filters applied: . Clear all
Page 1
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.
Baselga J, Campone M, Piccart M, Burris HA 3rd, Rugo HS, Sahmoud T, Noguchi S, Gnant M, Pritchard KI, Lebrun F, Beck JT, Ito Y, Yardley D, Deleu I, Perez A, Bachelot T, Vittori L, Xu Z, Mukhopadhyay P, Lebwohl D, Hortobagyi GN. Baselga J, et al. N Engl J Med. 2012 Feb 9;366(6):520-9. doi: 10.1056/NEJMoa1109653. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149876 Free PMC article. Clinical Trial.
Everolimus in HR-positive advanced breast cancer.
Tartarone A, Lerose R, Aieta M. Tartarone A, et al. N Engl J Med. 2012 May 3;366(18):1739; author reply 1739-40. doi: 10.1056/NEJMc1202719. N Engl J Med. 2012. PMID: 22551140 No abstract available.
Everolimus in HR-positive advanced breast cancer.
Massarweh S, Croley J, Weiss H. Massarweh S, et al. N Engl J Med. 2012 May 3;366(18):1738-9; author reply 1739-40. doi: 10.1056/NEJMc1202719. N Engl J Med. 2012. PMID: 22551139 No abstract available.
Everolimus: a new hope for patients with breast cancer.
Sendur MA, Zengin N, Aksoy S, Altundag K. Sendur MA, et al. Curr Med Res Opin. 2014 Jan;30(1):75-87. doi: 10.1185/03007995.2013.846253. Epub 2013 Oct 14. Curr Med Res Opin. 2014. PMID: 24050600 Review.
Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2.
Gnant M, Baselga J, Rugo HS, Noguchi S, Burris HA, Piccart M, Hortobagyi GN, Eakle J, Mukai H, Iwata H, Geberth M, Hart LL, Hadji P, El-Hashimy M, Rao S, Taran T, Sahmoud T, Lebwohl D, Campone M, Pritchard KI. Gnant M, et al. J Natl Cancer Inst. 2013 May 1;105(9):654-63. doi: 10.1093/jnci/djt026. Epub 2013 Feb 19. J Natl Cancer Inst. 2013. PMID: 23425564 Free PMC article. Clinical Trial.
93 results